Janssen says its Stelara maintained clinical remission in Crohn’s disease in Phase III trials
May 26, 2016Research and Development, Sales and Marketing Crohn’s disease, Janssen, Stelara, crohn's disease, drug trial
Janssen said its maintenance therapy for Crohn’s disease showed remission for patients in late-stage trials. The company said a significant …
Shares at Sarepta Therapeutics jump after FDA delay in drug approval review
May 26, 2016Research and Development, Sales and Marketing Duchenne Muscular Dystrophy, FDA, Sarepta Therapeutics, approval, delay, delayed announcement, muscular dystrophy, sarepta, treatment
Sarepta Therapeutics (NASDAQ: SRPT) has witnessed a sharp rise in the price of its shares after the US Food and …
US FDA committee recommends approval of Sanofi’s combination therapy for type 2 diabetes
May 26, 2016Research and Development, Sales and Marketing
French drug firm Sanofi (Euronext: SAN) said the US Food and Drug Administration (FDA) advisory committee has recommended the approval …
FDA approves CSL haemophilia A drug
May 26, 2016Sales and Marketing CSL, afstyla, haemophilia a, treatment
CSL (ASX: CSL) has announced that the US Food and Drug Administration (FDA) has approved Afstyla (antihaemophilic factor [recombinant), single …
NICE recommends Jevtana for advanced prostate cancer
May 25, 2016Sales and Marketing Jevtana, NICE, approval, prostate cancer, recommendation
The National Institute for Health and Care Excellence (NICE) has recommended Sanofi Genzyme’s Jevtana (cabazitaxel), in combination with prednisone or …
Sanofi makes move to remove Medivation board; Medivation hits back
May 25, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medivation, Sanofi, removal of board, takeover
Sanofi (NYSE: SNY) has taken their proposed takeover of Medivation (NASDAQ: MDVN) up several notches, with the French company filing …
Gilead names Kevin Young new chief operating officer
May 25, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead
Gilead Sciences (NASDAQ: GILD) has announced two new senior appointments, including Kevin Young as its new chief operating officer. Martin …
Eli Lilly showcases emerging pipeline to investors
May 25, 2016Research and Development Eli Lilly, investors, lilly, pipeline, research and development
Eli Lilly and Co (NYSE: LLY) has showcased its emerging pipeline to potential investors, highlighting its potential to launch 20 …
Monsanto rejects Bayer’s $62 billion offer
May 25, 2016Business Services, Research and Development, Sales and Marketing Bayer, Financial, M&A, MA, deal, monsanto
World’s largest seed maker Monsanto (NYSE: MON) has rejected the $62 billion takeover offer from Germany’s Bayer AG (ETR: BAYN) …
FDA committee unanimously recommends Novo Nordisk diabetes combo, IDegLira
May 25, 2016Research and Development, Sales and Marketing FDA, Novo Nordisk, Panel, Tresiba, Victoza, committee, ideglira, recommendation, staff
Novo Nordisk has announced that a US Food and Drug Administration (FDA) advisory committee has unanimously recommended IDegLira, a type-2 …
Nice recommends three drugs to treat diabetes
May 25, 2016Research and Development, Sales and Marketing AstraZeneca, BMS, Boehringer Ingelheim, Eli Lilly, Janssen, NICE, diabetes
The National Institute for Health and Care Excellence (Nice) has backed three drugs for the treatment of type 2 diabetes. …
Rare disease treatment advocates criticise NHS delays in commissioning
May 24, 2016Medical Communications, Sales and Marketing NHS, commissioning
Medical professionals are calling on NHS England to speed up access to treatment for patients with a rare genetic disease …
GSK says asthma drug Breo shows superior results over standard care in major study
May 24, 2016Research and Development, Sales and Marketing COPD, GSK, asthma, breo, drug trial
UK drugmaker GlaxoSmithKline (LSE: GSK) on Tuesday said inhaled medicine Breo proved significantly better than standard care in a major …
Focus: Regulators Enter the Drug Pricing Debate
May 24, 2016Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, pharma industry, regulation
By Anjali Shukla The Chinese authorities have come down strongly on the issue of drug costs, slashing the prices of …
MOD to ban use of Roche anti-malaria drug, Lariam, for armed forces
May 24, 2016Manufacturing and Production, Sales and Marketing anti-malaria drug, armed forces, lariam, mod
A parliamentary committee has published a new report urging the armed forces not to use anti-malaria drug, Lariam, due to …
Pfizer says EMA lifts warning on its smoking cessation drug Champix
May 24, 2016Manufacturing and Production, Research and Development, Sales and Marketing Champix, EMA, Pfizer, anti-smoking, drug trial
US pharma giant Pfizer (NYSE: PFE) said the European Medicines Agency has lifted a warning on its anti-smoking drug Champix …
CSL’s flu vaccine scores FDA approval
May 24, 2016Manufacturing and Production, Research and Development, Sales and Marketing CSL, FDA, Vaccine, flu, four strain, four-strain, influenza, influenza a, influenza b, seqirus
Seqirus, a division of CSL, has announced that the US Food and Drug Administration (FDA) has approved Flucelvax Quadrivalent (influenza …
Sandoz biosimilar accepted for regulatory submission by EMA
May 24, 2016Manufacturing and Production, Research and Development, Sales and Marketing EMA, Sandoz, biosimilar
Sandoz, a division of Novartis, has announced that the European Medicines Agency (EMA) has accepted its marketing authorisation application for …
US FDA advisors question usefulness of Sanofi’s combination diabetes therapy
May 24, 2016Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, US FDA, diabetes, drug trial, regulation
US Food and Drug Administration staff questioned the benefits of French drugmaker Sanofi’s (Euronext: SAN) diabetes drug candidate as well …
French authorities pins blame on Bial and Biotrial for fatal drug trial
May 24, 2016Manufacturing and Production, Research and Development Bial, Biotrial, France, blame, clinical trial, death, disaster, minister for health, report
Authorities in France have criticised the pharmaceutical company and the clinical research organisation at the centre of the Rennes clinical …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
